Nasdaq:NXTC

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

April 07, 2026 08:05 ET  | Source: NextCure The U.S. Food and Drug Administration (FDA) has granted Fast Track designation…

1 month ago

NextCure and Simceres SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026

The American Society for Clinical Oncology to be held in Chicago May 29 – June 2, 2026 March 31, 2026…

1 month ago